Mason Joe's Album: Wall Photos
Cloud-based
solutions for drug discovery, development and manufacturing market is
projected to grow at a CAGR of 15.4%, claims Roots Analysis
The growing complexities
surrounding modern therapy development initiatives have caused biopharmaceutical
companies to adopt available cloud-based solutions, to not only expedite
associated timelines, but also cuts down overall cost
Roots
Analysis has announced the addition of “Cloud-based
Solutions for Drug Discovery, Development and Manufacturing Market by Type of
Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a
Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS)),
End-User (Biotech Vendors, Contract Research Organizations, Pharmaceutical
Companies and Others), and Key Geographical Regions (North America, Europe,
Asia, Middle East and North Africa, Latin America, and Rest of the World):
Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
Modern cloud-based
solutions offer decentralized / real world data management, and collaborative
operating solutions to users, enabling the simplification and delegation of various
aspects of data mining, analysis and healthcare decision-making. The implementation of
relevant cloud-based solutions is deemed to possess the potential to save over
50% of the total cost and time invested in a drug development program.
To order this 225+ page report, which features 110+ figures
and 130+ tables, please visit https://www.rootsanalysis.com/reports/cloud-based-solutions-in-healthcare-market.html
Key Market Insights
More than 60 cloud-based service providers are presently
offering cloud-based solutions to pharma / biotech companies
Majority of these are
large firms (500+ employees, 44%), followed by small (1-50 employees,
32%), and mid-sized (51-500 employees, 24%) business entities.
Over 50 service
providers claim to offer cloud-based solutions for drug development
About 50% players are
providing cloud services for more than one area of application (drug
discovery, drug development, or drug manufacturing) to pharma / biotech
companies.
Nearly 30 service
providers claim to offer private cloud-based solutions to ensure data security
Interestingly, about
25% players are offering all three types of cloud-based solutions (private,
public and hybrid) to developer companies. Prominent examples of companies
offering hybrid cloud include (in alphabetical order with no selection
criteria) Informatica, Nutanix, QMENTA, Rescale, SureClinical, Tata
Consultancy Services and YASH Technologies.
Partnership activity in this field has grown at a CAGR of
~75%, between 2015 and 2020
Around 70% of the
reported deals were established after 2018, with the maximum activity being
reported in 2020. Majority of the instances captured in the report are research
agreements (32%) and platform development / improvement agreements (26%).
Adoption of cloud-based solutions has demonstrated the
ability to enable up to 50% cost savings
Based on inputs from
both secondary and primary sources, the report features an informed and
insightful analysis, estimating cost saving potential of cloud-based solutions.
In fact, the adoption of such technologies has the potential to save more than
USD 30 billion in drug discovery, USD 13 billion in drug development and USD
6.6 million in drug manufacturing related costs, by 2030.
North America, Europe and Asia are anticipated to capture over
85% of the market share by 2030
Owing to increased adoption rates, the market in Asia is
anticipated to grow at a relatively faster pace at a CAGR of 16%. In 2030, cloud-based
solutions for drug development are likely to capture the largest market share
(45%) in terms of revenues generated from use of such services, followed by those
intended for drug discovery (35%) and drug development (20%) operations.
To request a sample copy / brochure of this report, please
visit this https://www.rootsanalysis.com/reports/cloud-based-solutions-in-healthcare-market/request-sample.html
Key Questions Answered
§
Who are the leading
players offering cloud-based solutions for drug discovery, development and
manufacturing?
§
What kind of cloud
services are commonly offered by companies in this domain?
§
What kind of partnership
models are commonly adopted by stakeholders in this industry?
§
What is the likely
cost saving potential associated with the use of cloud-based solutions in drug
discovery, development and manufacturing processes?
§
How is the current
and future opportunity likely to be distributed across key market segments?
§
What kind of performance
enhancements are possible by integrating artificial intelligence, deep
learning, machine learning and quantum computing, with existing cloud-based
solutions?
§
What is the impact of
the COVID-19 pandemic within this market?
The USD 20 billion
(by 2030) financial opportunity within the cloud-based solutions for drug
discovery, drug development and drug manufacturing market has been analyzed
across the following segments:
§
Type of Cloud
Private
Public
Hybrid
§
Type of Cloud Service
IaaS
PaaS
SaaS
§
Area of Application
Drug
Discovery
Drug
Development
Drug
Manufacturing
§
End-User
Biotech
Vendor
Contract
Research Organizations
Pharmaceutical
Companies
Others
§
Key Geographical Regions
North
America
Europe
Asia-Pacific
Middle
East and North Africa
Latin
America
Rest
of the World
The research includes brief profiles of key players engaged
in offering cloud-based solutions for drug discovery, development and
manufacturing; other popular industry players featured in the report include:
§
Accenture
§
Alibaba Cloud
§
Amazon Web Services
§
ChemAxon
§
CloudSigma
§
Google
§
IBM
§
Nimbix
§
OpenEye Scientific
§
Oracle
§
Skyland Analytics
§
Veeva Systems
§
XtalPi
§
YPrime
You may also be interested in the following titles:
1.
Digital Solutions for Biomarkers
Market, 2021-2030
2. AI-based Drug Discovery Market: Focus on Deep Learning and Machine
Learning, 2020-2030
3. In Silico / Computer-Aided Drug
Discovery Services Market,
2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
solutions for drug discovery, development and manufacturing market is
projected to grow at a CAGR of 15.4%, claims Roots Analysis
The growing complexities
surrounding modern therapy development initiatives have caused biopharmaceutical
companies to adopt available cloud-based solutions, to not only expedite
associated timelines, but also cuts down overall cost
Roots
Analysis has announced the addition of “Cloud-based
Solutions for Drug Discovery, Development and Manufacturing Market by Type of
Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a
Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS)),
End-User (Biotech Vendors, Contract Research Organizations, Pharmaceutical
Companies and Others), and Key Geographical Regions (North America, Europe,
Asia, Middle East and North Africa, Latin America, and Rest of the World):
Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
Modern cloud-based
solutions offer decentralized / real world data management, and collaborative
operating solutions to users, enabling the simplification and delegation of various
aspects of data mining, analysis and healthcare decision-making. The implementation of
relevant cloud-based solutions is deemed to possess the potential to save over
50% of the total cost and time invested in a drug development program.
To order this 225+ page report, which features 110+ figures
and 130+ tables, please visit https://www.rootsanalysis.com/reports/cloud-based-solutions-in-healthcare-market.html
Key Market Insights
More than 60 cloud-based service providers are presently
offering cloud-based solutions to pharma / biotech companies
Majority of these are
large firms (500+ employees, 44%), followed by small (1-50 employees,
32%), and mid-sized (51-500 employees, 24%) business entities.
Over 50 service
providers claim to offer cloud-based solutions for drug development
About 50% players are
providing cloud services for more than one area of application (drug
discovery, drug development, or drug manufacturing) to pharma / biotech
companies.
Nearly 30 service
providers claim to offer private cloud-based solutions to ensure data security
Interestingly, about
25% players are offering all three types of cloud-based solutions (private,
public and hybrid) to developer companies. Prominent examples of companies
offering hybrid cloud include (in alphabetical order with no selection
criteria) Informatica, Nutanix, QMENTA, Rescale, SureClinical, Tata
Consultancy Services and YASH Technologies.
Partnership activity in this field has grown at a CAGR of
~75%, between 2015 and 2020
Around 70% of the
reported deals were established after 2018, with the maximum activity being
reported in 2020. Majority of the instances captured in the report are research
agreements (32%) and platform development / improvement agreements (26%).
Adoption of cloud-based solutions has demonstrated the
ability to enable up to 50% cost savings
Based on inputs from
both secondary and primary sources, the report features an informed and
insightful analysis, estimating cost saving potential of cloud-based solutions.
In fact, the adoption of such technologies has the potential to save more than
USD 30 billion in drug discovery, USD 13 billion in drug development and USD
6.6 million in drug manufacturing related costs, by 2030.
North America, Europe and Asia are anticipated to capture over
85% of the market share by 2030
Owing to increased adoption rates, the market in Asia is
anticipated to grow at a relatively faster pace at a CAGR of 16%. In 2030, cloud-based
solutions for drug development are likely to capture the largest market share
(45%) in terms of revenues generated from use of such services, followed by those
intended for drug discovery (35%) and drug development (20%) operations.
To request a sample copy / brochure of this report, please
visit this https://www.rootsanalysis.com/reports/cloud-based-solutions-in-healthcare-market/request-sample.html
Key Questions Answered
§
Who are the leading
players offering cloud-based solutions for drug discovery, development and
manufacturing?
§
What kind of cloud
services are commonly offered by companies in this domain?
§
What kind of partnership
models are commonly adopted by stakeholders in this industry?
§
What is the likely
cost saving potential associated with the use of cloud-based solutions in drug
discovery, development and manufacturing processes?
§
How is the current
and future opportunity likely to be distributed across key market segments?
§
What kind of performance
enhancements are possible by integrating artificial intelligence, deep
learning, machine learning and quantum computing, with existing cloud-based
solutions?
§
What is the impact of
the COVID-19 pandemic within this market?
The USD 20 billion
(by 2030) financial opportunity within the cloud-based solutions for drug
discovery, drug development and drug manufacturing market has been analyzed
across the following segments:
§
Type of Cloud
Private
Public
Hybrid
§
Type of Cloud Service
IaaS
PaaS
SaaS
§
Area of Application
Drug
Discovery
Drug
Development
Drug
Manufacturing
§
End-User
Biotech
Vendor
Contract
Research Organizations
Pharmaceutical
Companies
Others
§
Key Geographical Regions
North
America
Europe
Asia-Pacific
Middle
East and North Africa
Latin
America
Rest
of the World
The research includes brief profiles of key players engaged
in offering cloud-based solutions for drug discovery, development and
manufacturing; other popular industry players featured in the report include:
§
Accenture
§
Alibaba Cloud
§
Amazon Web Services
§
ChemAxon
§
CloudSigma
§
§
IBM
§
Nimbix
§
OpenEye Scientific
§
Oracle
§
Skyland Analytics
§
Veeva Systems
§
XtalPi
§
YPrime
You may also be interested in the following titles:
1.
Digital Solutions for Biomarkers
Market, 2021-2030
2. AI-based Drug Discovery Market: Focus on Deep Learning and Machine
Learning, 2020-2030
3. In Silico / Computer-Aided Drug
Discovery Services Market,
2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis